Improvement in Renal Function in High Immunologic Risk Kidney Transplant Recipients Switched From Tacrolimus to Belatacept

被引：1
|
作者：
Gupta, G. [1 ]
Kumar, D. [1 ]
Cotterell, A. [1 ]
Sharma, A. [1 ]
Posner, M. [1 ]
Ren, Q. [1 ]
Posner, S. [1 ]
King, A. [1 ]
机构：
[1] Virginia Commonwealth Univ, Richmond, VA 23284 USA
来源：
TRANSPLANTATION | 2014年 / 98卷
关键词：
D O I：
10.1097/00007890-201407151-01520
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
A203
引用
收藏
页码：457 / 457
页数：1
相关论文
共 50 条
  • [41] Short-term outcomes with no tapering tacrolimus to belatacept conversion in renal transplant recipients (RTR)
    Mattiazzi, Adela
    Balloveras, Katherine A.
    Centeno, Alexandra
    Cabrera, Pierina
    Uhlyar, Tiffany
    Pierre, Naomi
    Rivera, Franco Cabeza
    Guerra, Giselle
    TRANSPLANTATION, 2024, 108 (9S)
  • [42] Short-term outcomes with no tapering tacrolimus to belatacept conversion in renal transplant recipients (RTR)
    Mattiazzi, Adela
    Balloveras, Katherine A.
    Centeno, Alexandra
    Cabrera, Pierina
    Uhlyar, Tiffany
    Pierre, Naomi
    Rivera, Franco Cabeza
    Guerra, Giselle
    TRANSPLANTATION, 2024, 108 (09) : 561 - 561
  • [43] Belatacept Use in High Kidney Donor Profile Index Kidney Transplant Recipients.
    Britt, D.
    Gharabagi, A.
    Botkin, K.
    Horwedel, T.
    Carthon, C.
    Hagopian, J.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2019, 19 : 692 - 692
  • [44] Impact of Covid-19 on Belatacept and Tacrolimus Treated Kidney Transplant Recipients from a Prospective, Randomized, Multicenter Trial
    Chau, M. P.
    Shields, A. R.
    Alloway, R.
    Luckett, K.
    Cuffy, M.
    Govil, A.
    Kremer, J.
    Woodle, E.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2023, 23 (06) : S504 - S505
  • [45] Tacrolimus Concentration Variability Is Associated with Delayed Graft Function and Diminished Renal Function in Kidney Transplant Recipients.
    Makowski, C.
    Pilch, N.
    Meadows, H.
    Bratton, C.
    McGillicuddy, J.
    Chavin, K.
    Baliga, P.
    Taber, D.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2013, 13 : 471 - 471
  • [46] Evaluation of Twice-Daily Tacrolimus Switched to Once-Daily Tacrolimus in Kidney Transplant Recipients
    Min, D. I.
    Shah, T.
    Qazi, Y. A.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2023, 23 (06) : S952 - S953
  • [47] High risk of proteinuria and lack of improvement of kidney function following sirolimus conversion in liver transplant recipients
    Wadei, Hani M.
    Mai, Martin
    Ahsan, Nassim
    Rosser, Barry G.
    Gonwa, Thomas A.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2008, 8 : 543 - 543
  • [48] Kidney Function, Outcome and Pill Burden of Belatacept-Conversion in kidney-transplant recipients
    Bocchi, Federica
    Neuenschwander, Sascha
    Benackova, Katarina
    Sidler, Daniel
    SWISS MEDICAL WEEKLY, 2022, 152 : 10S - 10S
  • [49] Tacrolimus, MMF, steroid, and ALG immunotherapy for high immunological risk renal transplant recipients
    Zaltzman, J
    McAlister, V
    Russell, D
    Halloran, P
    Landsberg, D
    Busque, S
    Shoker, A
    Boucher, A
    Shapiro, J
    Tchervenkov, J
    Peets, J
    TRANSPLANTATION PROCEEDINGS, 2001, 33 (1-2) : 1044 - 1045
  • [50] Mycophenolic Acid Exposure in Belatacept or Tacrolimus When Combined with Early Steroid Withdrawal in Kidney Transplant Recipients
    Chau, M. P.
    Shields, A.
    Kremer, J.
    Kaur, J.
    Woodle, E.
    Alloway, R.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2023, 23 (06) : S429 - S430
12345